Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local
Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis....
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2000
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872000001100004 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720000011000042001-01-29Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento localCuchacovich T,MiguelPacheco B,PatricioMerino B,GuillermoGallardo V,PatriciaGatica R,HéctorValenzuela H,HernánVerdaguer D,JuanVerdaguer T,Juan Arthritis rheumatoid Epiescleritis Scleral diseases Scleritis Sjögren syndrome Vasculitis Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis. Patients and methods: Forty six patients with refractory scleritis and episcleritis were studied and treated during the period 1991 to 1998. Results: Necrotizing type was the most common and severe category in the scleritis group of patients. A decrease in vision occurred in 58.3% of patients with scleritis v/s a 23.5% of patients with epiescleritis (p<0,05). Uveitis was present in 35.4% of patients with scleritis and scleromalacia was present in 33.3% (p<0,05). A specific disease association was uncovered in 51% of scleritis and in 38% of episcleritis patients. Rheumatoid arthritis, primary systemic vasculitic disease and Sjögren syndrome with vasculitis were the most common associated systemic diseases. Three patients with scleritis had tuberculosis. Conclusions: Scleritis is more severe than episcleritis, and necrotizing scleritis is the most severe type of scleritis. Classification of scleritis and episcleritis provides valuable prognostic information. A meticulous approach for the detection of a specific associated disease must be undertaken. Scleritis associated with vasculitis has a worse ocular prognosis than other non infectious diseases. Cyclophosphamide is the most effective inmunosuppresive treatment to control severe ocular involvement (Rev Méd Chile 2000; 128: 1205-14)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.128 n.11 20002000-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004es10.4067/S0034-98872000001100004 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Arthritis rheumatoid Epiescleritis Scleral diseases Scleritis Sjögren syndrome Vasculitis |
spellingShingle |
Arthritis rheumatoid Epiescleritis Scleral diseases Scleritis Sjögren syndrome Vasculitis Cuchacovich T,Miguel Pacheco B,Patricio Merino B,Guillermo Gallardo V,Patricia Gatica R,Héctor Valenzuela H,Hernán Verdaguer D,Juan Verdaguer T,Juan Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
description |
Background: Scleritis and episcleritis may extend to adjacent ocular tissues with blinding consequences and may be associated with potentially lethal systemic disorders. Aim: To evaluate the ocular complications and systemic disease associations of the different types of scleritis and episcleritis. Patients and methods: Forty six patients with refractory scleritis and episcleritis were studied and treated during the period 1991 to 1998. Results: Necrotizing type was the most common and severe category in the scleritis group of patients. A decrease in vision occurred in 58.3% of patients with scleritis v/s a 23.5% of patients with epiescleritis (p<0,05). Uveitis was present in 35.4% of patients with scleritis and scleromalacia was present in 33.3% (p<0,05). A specific disease association was uncovered in 51% of scleritis and in 38% of episcleritis patients. Rheumatoid arthritis, primary systemic vasculitic disease and Sjögren syndrome with vasculitis were the most common associated systemic diseases. Three patients with scleritis had tuberculosis. Conclusions: Scleritis is more severe than episcleritis, and necrotizing scleritis is the most severe type of scleritis. Classification of scleritis and episcleritis provides valuable prognostic information. A meticulous approach for the detection of a specific associated disease must be undertaken. Scleritis associated with vasculitis has a worse ocular prognosis than other non infectious diseases. Cyclophosphamide is the most effective inmunosuppresive treatment to control severe ocular involvement (Rev Méd Chile 2000; 128: 1205-14) |
author |
Cuchacovich T,Miguel Pacheco B,Patricio Merino B,Guillermo Gallardo V,Patricia Gatica R,Héctor Valenzuela H,Hernán Verdaguer D,Juan Verdaguer T,Juan |
author_facet |
Cuchacovich T,Miguel Pacheco B,Patricio Merino B,Guillermo Gallardo V,Patricia Gatica R,Héctor Valenzuela H,Hernán Verdaguer D,Juan Verdaguer T,Juan |
author_sort |
Cuchacovich T,Miguel |
title |
Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
title_short |
Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
title_full |
Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
title_fullStr |
Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
title_full_unstemmed |
Características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
title_sort |
características clínicas y respuesta al tratamiento sistémico de la epiescleritis y escleritis primarias y secundarias, refractarias al tratamiento local |
publisher |
Sociedad Médica de Santiago |
publishDate |
2000 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872000001100004 |
work_keys_str_mv |
AT cuchacovichtmiguel caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT pachecobpatricio caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT merinobguillermo caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT gallardovpatricia caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT gaticarhector caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT valenzuelahhernan caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT verdaguerdjuan caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal AT verdaguertjuan caracteristicasclinicasyrespuestaaltratamientosistemicodelaepiescleritisyescleritisprimariasysecundariasrefractariasaltratamientolocal |
_version_ |
1718435943510179840 |